Inspire Investing, LLC

Position in PGEN — Precigen, Inc.

CIK 1670139 MERIDIAN, ID

Position in PGEN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$679,713

+$152,921 QoQ

Shares Held

119,248

-12.4% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#80

of 210 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Inspire Investing, LLC holds $37,341,309 across 53 Biotechnology names. PGEN ranks #16 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	79,780	$4,473,264
2	EXEL	Exelixis, Inc.	79,532	$4,327,336
3	INCY	Incyte Corp	33,749	$3,825,786
4	JAZZ	Jazz Pharmaceuticals plc	15,859	$3,821,543
5	ROIV	Roivant Sciences Ltd.	74,085	$2,621,868
6	ZVRA	Zevra Therapeutics, Inc.	173,016	$2,481,049
7	RVMD	Revolution Medicines, Inc.	8,616	$1,613,604
8	INSM	INSMED Inc	11,287	$1,203,419

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$679,713	119,248	-12.4%	Shares	Sole	2026-08-12
2026-03-31	$526,792	136,122	+23.3%	Shares	Sole	2026-04-23
2025-12-31	$461,459	110,397	-17.8%	Shares	Sole	2026-02-17
2025-09-30	$441,603	134,226	-51.3%	Shares	Sole	2025-10-15
2025-06-30	$391,735	275,870	+17.3%	Shares	Sole	2025-07-24
2025-03-31	$350,316	235,112	+879.4%	Shares	Sole	2025-06-03
2022-12-31	$36,489	24,006	-17.0%	Shares	Sole	2023-01-26
2022-09-30	$61,329	28,929	+10.5%	Shares	Defined	2022-11-07
2022-06-30	$35,067	26,170	+57.5%	Shares	Defined	2022-08-10
2022-03-31	$35,059	16,616	+47.1%	Shares	Defined	2022-04-21
2021-12-31	$41,904	11,295	-7.3%	Shares	Sole	2022-02-14
2020-09-30	$42,633	12,181	+7.7%	Shares	Sole	2020-11-16
2020-06-30	$56,451	11,313	+30.7%	Shares	Sole	2020-08-12
2020-03-31	$29,440	8,659	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.